Dysmenorrhea, endometriosis and premenstrual syndrome;Dismenorrea, endometriosi e sindrome premestruale

Minerva Pediatrica

Volumn 54, Issue 6, 2002, Pages 525-538

  Tonini, G ^a  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Adolescence; Anti inflammatory agents, non steroidal; Contraceptives, oral; Dysmenorrhea; Endometriosis; Gonadorelin; Menstrual cycle; Premenstrual syndrome; Prostaglandins; Serotonin

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIESTROGEN; BENZODIAZEPINE; CALCIUM ANTAGONIST; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DANAZOL; ESTROGEN; FLUOXETINE; GESTRINONE; GONADORELIN; GONADORELIN AGONIST; IBUPROFEN; INDOMETACIN; LEUPRORELIN; MAGNESIUM; MEDROXYPROGESTERONE ACETATE; NAPROXEN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PROSTAGLANDIN; PYRIDOXINE; ROFECOXIB; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SPIRONOLACTONE; TRIPTORELIN;

ABDOMINAL PAIN; ACNE; ACUPUNCTURE; ADOLESCENCE; ADOLESCENT; CONFERENCE PAPER; CULTURAL FACTOR; DAILY LIFE ACTIVITY; DIETARY INTAKE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; DYSMENORRHEA; ECONOMIC ASPECT; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; FEMALE GENITAL TRACT MALFORMATION; GENETICS; HIRSUTISM; HUMAN; LAPAROSCOPY; LIFESTYLE; MENSTRUAL IRREGULARITY; NEOVASCULARIZATION (PATHOLOGY); PHYSICAL ACTIVITY; PREMENSTRUAL SYNDROME; RELAXATION TRAINING; SOCIAL ASPECT; SYMPTOM; TRADITIONAL MEDICINE; TREATMENT FAILURE; TREATMENT INDICATION; UTERUS BIOPSY; UTERUS BLOOD FLOW; UTERUS CONTRACTILITY; UTERUS SYNECHIA; VAGINA ATROPHY; YOGA;

ADOLESCENT; DYSMENORRHEA; ENDOMETRIOSIS; FEMALE; HUMANS; PREMENSTRUAL SYNDROME;

EID: 0036919081     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (73)

1. Banikarim C, Chacko MR, Kelder SH. Prevalence and impact of dysmenorrhea on Hispanic female adolescents. Arch Pediatr Adolesc Med 2000;154:1226-9.
2. Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 1996;87:55-8.
3. Baines PA, Allen GM. Pelvic pain and menstrual related illnesses. Emerg Med Clin North Am 2001;19: 763-80.
4. Schroeder B, Sanfilippo JS. Dysmenorrhea and pelvic pain in adolescents. Pediatr Clin North Am. 1999;46: 555-71.
5. Cramer DW, Missmer SA. The epidemiology of endometriosis. Ann N Y Acad Sci 2002;955:11-22;discussion 34-6, 396-406.
6. Sanfilippo JS. Oh, the dilemma of dysmenorrhea - What's new? J Pediatr Adolesc Gynecol 2001;14:1-2.
7. Alonso C, Coe CL. Disruptions of social relationships accentuate the association between emotional distress and menstrual pain in young women. Health Psychol 2001;20:411-6.
8. Chang MY, Chiang CH, Shiau CS. Familial trend of dysmenorrhea and endometriosis-a study from members of endometriosis association, Taiwan. Fertil Steril 2002;77 Suppl 1:S33.
9. Akerlund M. Vascularization of human endometrium. Uterine blood flow in healthy condition and in primary dysmenorrhoea. Ann N Y Acad Sci 1994;734: 47-56.
10. Dmitrovic R. Transvaginal color Doppler study of uterine blood flow in primary dysmenorrhea. Acta Obstet Gynecol Scand 2000;79:1112-6.
11. Harel Z, Lilly C, Riggs S, Vaz R, Drazen J. Urinary leukotriene (LT) E(4) in adolescents with dysmenorrhea: A pilot study. J Adolesc Health 2000;27:151-4.
12. Abu JI, Konje JC. Leukotrienes in gynaecology: The hypothetical value of anti-leukotriene therapy in dysmenorrhoea and endometriosis. Hum Reprod Update 2000;6:200-5.
13. Stromberg P, Akerlund M, Forsling ML, Granstrom E, Kindahl H. Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea. Acta Obstet Gynecol Scand 1984;63:533-8.
14. Bulletti C, de Ziegler D, Polli V, Diotallevi L, Del Ferro E, Flamigni C. Uterine contractility during the menstrual cycle. Hum Reprod 2000;15 Suppl 1:81-9.
15. Balbi C, Musone R, Menditto A, Di Prisco L, Cassese E, D'Ajello M, Ambrosio D, Cardonel A. Influence of menstrual factors and dietary habits on menstrual pain in adolescence age. Eur J Obstet Gynecol Reprod Biol 2000;91:143-8.
16. Barnard ND, Scialli AR, Hurlock D, Bertron P. Diet and sex-hormone binding globulin, dysmenorrhea, and premenstrual symptoms. Obstet Gynecol 2000;95:245-50.
17. Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol 1990;97:588-94.
18. Parazzini F, Tozzi L, Mezzopane R, Luchini L, Marchini M, Fedele L. Cigarette smoking, alcohol consumption, and risk of primary dysmenorrhea. Epidemiology 1994;5:469-72.
19. Harlow SD, Park M. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol 1996;103:1134-42.
20. Wu D, Wang X, Chen D, Niu T, Ni J, Liu X, Xu X. Metabolic gene polymorphisms and risk of dysmenorrhea. Epidemiology 2000;11:648-53.
21. Porpora MG, Picarelli A, Prosperi Porta R, Di Tola M, D'Elia C, Cosmi EV. Celiac disease as a cause of chronic pelvic pain, dysmenorrhea, and deep dyspareunia. Obstet Gynecol 2002;99(5 Suppl 1);937-9.
22. Wilson ML, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Nurs Times 2001;97:44.
23. Rice VM. Conventional medical therapies for endometriosis [review]. Ann N Y Acad Sci 2002;955:343-52;discussion 389-93,396-406.
24. Griffiths V. Traditional Chinese medicine: A case of dysmenorrhoea. Aust J Holist Nurs 2000;7:42-3.
25. Proctor ML, Smith CA, Farquhar CM, Stones RW. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea. Cochrane Database Syst Rev 2002:CD002123.
26. Proctor ML, Hing W, Johnson TC, Murphy PA. Spinal manipulation for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2001:CD002119.
27. Ernst E, Harkness E. Spinal manipulation: A systematic review of sham controlled, double-blind, randomized clinical trials. J Pain Symptom Manage 2001;22:879-89.
28. Campbell MA, McGrath PJ. Non-pharmacologic strategies used by adolescents for the management of menstrual discomfort. Clin J Pain 1999;15:313-20.
29. Kaplan B, Peled Y, Pardo J, Rabinerson D, Hirsh M, Ovadia J et al. Transcutaneous electrical nerve stimulation (TENS) as a relief for dysmenorrhea. Clin Exp Obstet Gynecol 1994;21:87-90.
30. Ziaei S, Faghihzadeh S, Sohrabvand F, Lamyian M, Emamgholy T. A randomised placebo-controlled trial to determine the effect of vitamin E in treatment of primary dysmenorrhoea. BJOG 2001;108:1181-3.
31. Zhang WY, Li Wan Po A. Efficacy of minor analgesics in primary dysmenorrhoea: A systematic review. Br J Obstet Gynaecol 1998;105:780-9.
32. Dawood MY. Nonsteroidal antiinflammatory drugs and reproduction. Am J Obstet Gynecol 1993;169: 1255-65.
33. Facchinetti F, Sgarbi L, Piccinini F, Volpe A. A comparison of glyceryl trinitrate with diclofenac for the treatment of primary dysmenorrhea: An open, randomized, cross-over trial. Gynecol Endocrinol 2002;16:39-43.
34. Morrison BW, Daniels SE, Kotey P, Cantu N, Seidenberg B. Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: A randomized controlled trial. Obstet Gynecol 1999;94:504-8.
35. Frontino G, Vercellini P, De Giorgi O, Zaina B, Pisacreta A, Crosignani PG. Continuous use of oral contraceptive (OC) for endometriosis-associated recurrent dysmenorrhea not responding to cyclic pill regimen. Fertil Steril 2002;77 Suppl 1:S23-4.
36. Davis AR, Westhoff CL. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol 2001;14:3-8.
37. Davis AR, Westhoff CL. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Oynecol 2001;14:3-8.
38. Sulak PJ, Cressman BE, Waldrop E, Holleman S, Kuehl TJ. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol 1997;89:179-83.
39. Roets L, van Rijswijck O. Endometriosis in tampon users. Curationis 1999;22:12-5.
40. Arvanitis DA, Goumenou AG, Matalliotakis IM, Koumantakis EE, Spandidos DA. Low-penetrance genes are associated with increased susceptibility to endometriosis. Fertil Steril 2001;76:1202-6.
41. Akoum A, Lawson C, McColl S, Villeneuve M. Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro: Mol Hum Reprod 2001;7:859-66.
42. Murphy AA. Clinical aspects of endometriosis. Ann N Y Acad Sci 2002;955:1-10;discussion 34-6,396-406.
43. Porpora MG, Koninckx PR, Piazze J, Natili M, Colagrande S, Cosmi EV. Correlation between endometriosis and pelvic pain. J Am Assoc Gynecol Laparosc 1999;6:429-34.
44. Murphy AA. Clinical aspects of endometriosis. Ann N Y Acad Sci 2002;955:1-10;discussion 34-6,396-406.
45. Porpora MG, Koninckx PR, Piazze J, Natili M, Colagrande S, Cosmi EV. Correlation between endometriosis and pelvic pain. J Am Assoc Gynecol Laparosc 1999;6:429-34.
46. Audebert A. Characteristics of adolescent endometriosis: Apropos of a series of 40 cases. Gynecol Obstet Fertil 2000;28:450-4.
47. Mara M, Fucikova Z, Kuzel D, Dohnalova A, Haakova L, Zivny J. Laparoscopy in chronic pelvic pain - A retrospective clinical study. Ceska Gynekol (Czech) 2002;67:38-46.
48. Walter AJ, Hentz JG, Magtibay PM, Cornella JL, Magrina JF. Endometriosis: Correlation between histologic and visual findings at laparoscopy. Am J Obstet Gynecol 2001;184:1407-13.
49. Gupta A, Kumar S, Chadha P, Sethi R, Pandey Y. Early laparoscopy for abdominal pain. Lancet 2000;355:2251.
50. Frontino G, Vercellini P, De Giorgi O, Zaina B, Pisacreta A, Crosignani PG. Continuous use of oral contraceptive (OC) for endometriosis-associated recurrent dysmenorrhea not responding to cyclic pill regimen. Fertil Steril 2002;77 Suppl 1:S23-4.
51. Bergqvist A, Theorell T. Changes in quality of life after hormonal treatment of endometriosis. Acta Obstet Gynecol Scand 2001;80p:628-37.
52. Lindheim SR. Chronic pelvic pain: Presumptive diagnosis and therapy using GnRH agonists. Int J Fertil Womens Med 1999;44;131-8.
53. Bergqvist A. A comparative study of the acceptability and effect of goserelin and nafarelin on endometriosis. Gynecol Endocrinol 2000;14:425-32.
54. Miller JD. Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial. Am J Obstet Gynecol 2000;182:1483-8.
55. Porpora MG, Picarelli A, Prosperi Porta R, Di Tola M, D'Elia C, Cosmi EV. Celiac disease as a cause of chronic pelvic pain, dysmenorrhea, and deep dyspareunia. Obstet Gynecol 2002;99(5 Suppl 1):937-9.
56. Craninx M, D'Haens G, Cokelaere K, Baert F, Penninckx F, D'Hoore A et al. Crohn's disease and intestinal endometriosis: An intriguing co-existence. Eur J Gastroenterol Hepatol 2000;12:217-21.
57. Freeman EW, Halbreich U. Premenstrual syndromes. Psychopharmacol Bull 1998;34:291-5.
58. Steiner M. Premenstrual syndrome and premenstrual dysphoric disorder: Guidelines for management. J Psychiatry Neurosci 2000;25:459-68.
59. Steiner M. Recognition of premenstrual dysphoric disorder and its treatment. Lancet 2000;356:1126-7.
60. Ugarriza DN, Klingner S, O'Brien S. Premenstrual syndrome: diagnosis and intervention. Nurse Pract 1998;23:40,45,49-52 passim.
61. Hartlage SA, Arduino KE, Gehlert S. Premenstrual dysphoric disorder and risk for major depressive disorder: A preliminary study. J Clin Psychol 2000;57: 1571-8.
62. Cleckner-Smith CS, Doughty AS, Grossman JA. Premenstrual symptoms. Prevalence and severity in an adolescent sample. J Adolesc Health 1998;22:403-8.
63. Hylan TR, Sundell K, Judge R. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: Experience from the United States, United Kingdom, and France. J Womens Health Gend Based Med 1999;8:1043-52.
64. Verri A, Nappi RE, Vallero E, Galli C, Sances G, Martignoni E. Premenstrual dysphoric disorder and eating disorders. Cephalalgia 1997;17 Suppl 20:25-8.
65. Golding JM, Taylor DL, Menard L, King MJ. Prevalence of sexual abuse history in a sample of women seeking treatment for premenstrual syndrome. J Psychosom Obstet Gynaecol 2000;21:69-80.
66. Jamieson DJ, Steege JF. The association of sexual abuse with pelvic pain complaints in a primary care population. Am J Obstet Gynecol 1997;177:1408-12.
67. Steiner M, Born L. Diagnosis and treatment of premenstrual dysphoric disorder: An update. Int Clin Psychopharmacol 2000;15 Suppl 3:S5-17.
68. Walker AF, De Souza MC, Vickers MF, Abeyasekera S, Collins ML, Trinca LA. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health 1998;7:1157-65.
69. Stevinson C, Ernst E. A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome. BJOG 2000;107:870-6.
70. Walsh MJ, Polus BI. The frequency of positive common spinal clinical examination findings in a sample of premenstrual sindrome sufferers. J Manipulative Physiol Ther 1999;22:216-20.
71. Steiner M, Pearlstein T. Premenstrual dysphoria and the serotonin system: Pathophysiology and treatment. J Clin Psychiatry 2000;61 Suppl 12:17-21.
72. Freeman EW, Sondheimer SJ, Polansky M, Garcia-Espagna B. Predictors of response to sertraline treatment of severe premenstrual syndromes. J Clin Psychiatry 2000;61:579-84.
73. Freeman EW, Rickels K, Arredondo F, Kao LC, Pollack SE, Sondheimer SJ. Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant. J Clin Psychopharmacol 1999;19:3-8.